Strata Oncology
PrivateLast Round
Series C
Extension
Nov 22, 2024
Total Funding Raised
$139.15M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Strata Oncology is a healthcare and biotechnology company that accelerates the impact of precision medicine for cancer patients by partnering with major healthcare systems to provide rapid genomic sequencing of tumor biopsies, enabling tailored therapies and drug trials.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Strata Oncology Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Strata Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Nov 22, 2024 | ||||
| Series C | Jul 28, 2021 | ||||
| Series B Extension | Nov 4, 2020 | ||||
| Series B | May 23, 2018 | ||||
| Series A | Jun 1, 2016 |
Key People
Founding team and executive leadership
Strata Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series C, Series B |
| Arboretum Ventures | Series C, Series B, Series A |
| Highside Capital Management | Series C |
| Baird Capital | Series C, Series B, Series A |
| HIGHSIDE Global | Series C |
| Pfizer Ventures | Series C, Series B |
| eLab Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 65% MoM.
Strata Oncology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Strata Oncology's valuation, stock price, and market status.